HIGHLIGHTS
- who: Azoospermia and colleagues from the Universidade Estadual de (UNICAMP), BrasilBrasil have published the research: Recombinant gonadotropin therapy to improve spermatogenesis in nonobstructive azoospermic patients - A proof of concept study _______________________________________________, in the Journal: (JOURNAL)
- what: The authors report a series of eight NOA males who received long-term treatment with recombinant human chorionic gonadotropin twice a week for spermatogenesis stimulation. The aim of this study was to evalu- ate the role of recombinant gonadotropin therapy for spermatogenesis stimulation in patients with NOA due to spermatogenic failure. Strengths and Limitations the study has several limitations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.